Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Daria A. Bogdanova has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    5-Azacytidine Reprograms Colorectal Cancer Cells Toward Senolytic Vulnerability and Enhanced T-Cell-Mediated Cytotoxicity

    by Darya A. Lisitsa, Ekaterina D. Kolosova, Natalia A. Budkina, Viktoria M. Petrova, Oleg N. Demidov, Daria A. Bogdanova

    Aberrant DNA methylation is a hallmark of colorectal cancer (CRC) and represents a potential therapeutic target. DNA methyltransferase inhibitors can induce sustained transcriptional and phenotypic reprogramming of tumor cells; however, the therapeutic vulnerabilities created by this reprogramming are not completely understood. Here, we investigated the effects of 5-azacitidine (5-AZA) in the human CRC cell lines HT-29 and DLD-1 and assessed whether epigenetic priming could subsequently be exploited using senolytic or immunotherapeutic approaches. Treatment with 5-AZA reduced cell proliferation and induced a senescent phenotype accompanied by increased expression of the cyclin-dependent kinase inhibitors CDKN1A and CDKN2B and anti-apoptotic BCL-2 family proteins as well as p16 expression on protein level. These changes were most pronounced in HT-29 cells. Pretreatment with 5-AZA sensitized HT-29 cells to navitoclax, a broad-spectrum BH3 mimetic, whereas the selective BCL-2 inhibitor venetoclax was less effective. In DLD-1 cells, both the senescent phenotype and sensitization to navitoclax were less pronounced, indicating that the response to epigenetic priming is dependent on tumor-cell context. By contrast, in an in vitro immunotherapy model using DLD-1 tumor cells, lymphocytes and a bispecific CD19 × CD3 T-cell engager (BiTE), pretreatment of tumor cells with 5-AZA enhanced T-cell-mediated cytotoxicity and increased IFN-γ production. Thus, 5-AZA induces therapeutically relevant reprogramming of CRC cells, sensitizing them to navitoclax while simultaneously increasing their susceptibility to T-cell-mediated elimination. These findings provide a rationale for further investigation of sequential treatment strategies combining epigenetic priming with senolytic or immunotherapeutic approaches.

  • Open Access

    The role of the PPM1D gene in the carcinogenesis of myeloid neoplasms: molecular mechanisms and prospects for targeted therapy

    by E. D. Kolosova, D. A. Bogdanova, O. N. Demidov

    Objective : to summarize the accumulated knowledge on the role of PPM1D phosphatase in clonal hematopoiesis and the pathogenesis of hematological malignancies, particularly in acute myeloid leukemia, as well as to evaluate the feasibility of therapeutic targeting of PPM1D using specific inhibitors. Materials and Methods . A search for relevant sources was conducted in the Web of Science, PubMed, and Scopus databases. Publications were selected based on the relevance of the studies and the pertinence of their subject matter to the topic of the review, the literature search was performed using the following key terms: “mutations of PPM1D ", “PPM1D and cancer”, “clonal hematopoiesis”, “PPM1D and clonal hematopoiesis”, “ PPM1D gene”, “WIP1 phosphatase”, “clonal hematopoiesis of indeterminate potential”, “therapy-related AML”, “p53 signaling pathway”, “cell cycle regulation”, “targeted cancer therapy”, “hematologic malignancies”, “truncating mutations” and “inhibitors of PPM1D”. A total of 142 sources were analyzed, of which 63 were included in the review. Results. Clonal hematopoiesis of indeterminate potential (CHIP) is characterized as a condition involving somatic mutations in driver genes of myeloid neoplasms at a variant allele frequency of ≥2 % in blood cells of individuals without hematological disorders. The prevalence of CHIP exceeds 10 % in individuals over 60 years of age and reaches 25 % in cancer patients. Antineoplastic therapy promotes the selection of hematopoietic stem cell clones harboring mutations, including mutations in the PPM1D gene, which substantially increases the risk of developing therapy-related myeloid neoplasms (t-MN). PPM1D phosphatase is a negative regulator of p53 and numerous cell death pathways. Its overexpression is detected in various types of solid tumors (ovarian cancer, breast cancer, and others), while its mutations are identified in 1-2 % of patients with de novo myeloid neoplasms and in 10-20 % of patients with t-MN. Recent studies demonstrate the predominant role of PPM1D mutations in age-associated clonal hematopoiesis, in the context of telomere shortening, and in the presence of germline DNA repair mutations, thereby underscoring the pivotal significance of this phosphatase in the pathogenesis of myeloid disorders. Conclusion. PPM1D represents a promising therapeutic target for the treatment of AML owing to its key role in the regulation of multiple cell death pathways and the cellular stress response. PPM1D inhibitors may serve as a foundation for the development of combination therapy regimens, particularly for elderly patients and those with acquired resistance to antineoplastic agents.

  • Bioluminescent xenograft model of acute myeloid leukemia for immunotherapy preclinical studies

    by Dina Senichkina, Tamara Pukhalskaia, Daria Bogdanova, Eugenia Platonova, Olga Epifanovskaya, Ivan Gaponenko, Daria Smirnova, Anna Malashicheva, Andrey Russiyanov, Ekaterina Malakhova, et al.

  • Open Access

    PPM1D OVEREXPRESSION LEADS TO A PROINFLAMMATORY CYTOKINE PROFILE IN RESPONSE TO NF-κB ACTIVATION IN A HUMAN COLORECTAL CANCER CELL LINE

    by Ekaterina D. Kolosova, Darya A. Lisitsa, Oleg N. Demidov, Daria A. Bogdanova, Лисица Дарья Андреевна

    Protein phosphatase PPM1D (Protein phosphatase, Mg²⁺/Mn²⁺ dependent, 1D) is one of the key regulators of DNA damage-induced stress response, cell cycle and apoptosis. PPM1D overexpression is detected in a large number of both solid (lung cancer, breast cancer, etc.) and hematological (acute myeloid leukemia) malignancies, making PPM1D an important prognostic marker in oncology. Special attention should be paid to PPM1D overexpression in colorectal cancer (CRC), the third most common oncological disease, because this indicator correlates with increased tumor size, metastasis, unfavorable survival prognosis, and the development of drug resistance. Drug resistance may be associated with the fact that PPM1D directly dephosphorylates p53 and other components of the ATM-p53 signaling pathway, and also acts as a negative regulator of NF-κB. It is likely that PPM1D overexpression in CRC tumor cells may lead to a decrease in the synthesis of important proinflammatory cytokines and the development of an immunosuppressive tumor microenvironment, which can significantly worsen the outcome of therapy. At present, the role of PPM1D in regulating the inflammatory response in CRC remains insufficiently studied. The aim of this study is to compare the effect of chemical inhibition of PPM1D using its selective inhibitor GSK2830371 and genetic knockout of PPM1D on the human colorectal cancer cell line HT-29 under conditions of NF-κB signaling pathway induction with TNF treatment. In this work, the human colorectal cancer cell line HT-29 was used, as well as previously obtained HT-29 cell line with PPM1D gene knockout and HT-29 cell line with PPM1D overexpression. Cell lines were cultured under standard conditions. For experiments, TNF at a concentration of 20 ng/ml and GSK2830371 at a concentration of 10 μM were used. Cell lines were incubated with GSK2830371 for 24 hours and with TNF for 12 hours. Cytokine production was evaluated using xMAP INTELLIFLEX multiplex technology and gene expression was measured by real-time PCR. The multiplex assessment of cytokine secretion levels revealed that neither the incubation of cells with GSK2830371 nor PPM1D knockout led to changes in the cytokine profile without stimulation compared to the intact cell line, and did not cause a significant increase in the production of pro-inflammatory cytokines and growth factors in the case of NF-κB pathway stimulation using TNF. In the case of NF-κB pathway simulation with TNF and PPM1D inhibition, no significant increase in the production of proinflammatory cytokines and growth factors was detected. When evaluating the HT-29 cell line with PPM1D overexpression using real-time PCR, a statistically significant increase in the expression levels of TNF, IL-8, and IL-1b was observed in response to TNF treatment compared to the wild-type line. This finding is inconsistent with data on the negative regulation of the NF-κB pathway by PPM1D phosphatase. As a result of the work, it was shown that PPM1D gene knockout didn’t significantly affect the level of cytikines (IL-8, GM-CSF, etc.) controlled by the trascription factor NF-κB in the case of TNF induction, compared with the use of the selective inhibitor GSK2833071. At the same time, overexpression of PPM1D led to an increase in the expression of proinflammotory cytokine genes, such as IL-8, TNF, IL-1b, upon induction of the NF-κB pathway by TNF.

  • Open Access

    Detection and Phylogenetic Analysis of Alphacoronaviruses in Bat Populations of Rostov and Novosibirsk Regions of Russia, 2021–2023

    by Olesia V. Ohlopkova, Igor V. Popov, Ilia V. Popov, Kristina A. Stolbunova, Marina A. Stepanyuk, Alexey D. Moshkin, Aleksei A. Maslov, Ivan A. Sobolev, Aleksey V. Malinovkin, Elizaveta V. Tkacheva, et al.

    Bats are natural reservoirs for many emerging viruses, including coronaviruses that were probably progenitors to human coronaviruses with epidemic and pandemic potential, which highlights the importance of screening studies of bat-derived viruses. This study investigates the prevalence and phylogenetic characteristics of coronaviruses in bat populations from the Rostov and Novosibirsk regions of Russia between 2021 and 2023. Utilizing PCR screening and sequencing, viruses belonging to the Alphacoronavirus genus were detected in several bat species, with prevalence rates ranging from 4.94% to 62.5%. Phylogenetic analysis of detected sequences revealed the presence of three subgenera: Pedacovirus, Myotacovirus, and Nyctacovirus. These sequences shared over 90% identity with alphacoronaviruses previously identified in bats across Northern Europe and Russia, underscoring the viruses’ wide geographic distribution and evolutionary connections. The results highlight the adaptability of alphacoronaviruses and the role of bat migratory behavior in their dispersal. The study underscores the importance of continuous monitoring and phylogenetic studies of bat-derived coronaviruses to better understand their ecological dynamics and potential zoonotic threats.


  • Open Access

    Myeloid Cell Mobilization and Recruitment by Human Mesothelioma in NSG-SGM3 Mice

    by Vadim V. Shindyapin, Ekaterina O. Gubernatorova, Ekaterina A. Gorshkova, Nelya R. Chicherina, Fedor A. Sysonov, Anastasia S. Yakovleva, Daria A. Bogdanova, Oleg N. Demidov, Mariya V. Samsonova, Vladimir P. Baklaushev, et al.

    Malignant pleural mesothelioma is a neoplasm that is often detected late due to nonspecific symptoms. This study utilized NSG-SGM3 mice to examine interactions between a human-derived mesothelioma reporter cell line (MZT-Luc2-mCherry) and the host’s myeloid compartment. Tumor growth was assessed using optical tomography, while cytokine/chemokine production was analyzed via multiplex assay. Histological and immunohistochemical analyses validated the epithelioid mesothelioma phenotype. In vitro mesothelioma cells secreted factors associated with myeloid cell chemoattraction and functions supporting the previously reported myeloid-biased secretory phenotype. In line with this, post-engraftment analysis revealed increased neutrophil-like Ly6G+ populations and decreased Ly6C+ inflammatory monocytes in the blood of tumor-bearing mice. Significant Ly6G+ cell infiltration was observed in the tumor, while CD11b+ myeloid cells were localized primarily in the tumor periphery. Tumor lysates showed increased levels of neutrophil chemoattractants and G-CSF, suggesting a previously not reported role of neutrophils in mesothelioma progression. This novel model provides a platform for studying mesothelioma–host interactions, focusing on the myeloid compartment. It may also serve as a tool to facilitate the development of new therapeutic strategies targeting myeloid cell-mediated mechanisms in mesothelioma.


  • Open Access

    PP2C phosphatases—terminators of suicidal thoughts

    by Lisa Lagorgette, Daria A. Bogdanova, Ekaterina V. Belotserkovskaya, Carmen Garrido, Oleg N. Demidov

    Cell death and related signaling pathways are essential during development and in various physiological and pathological conditions. Post-translational modifications such as ubiquitination and phosphorylation play an important role in these signaling pathways. The involvement of kinases - enzymes that catalyze protein phosphorylation - in cell death signaling has been extensively studied. On the other hand, not many studies have been devoted to analyzing the role in cell death of phosphatases, enzymes involved in the removal of phosphorylated residues added to proteins by kinases. Obviously, the two opposite reactions, phosphorylation and dephosphorylation, are equally important in the regulation of protein functions and subsequently in the execution of the cell death program. Here, we have summarized recent work on the involvement of serine-threonine PP2C phosphatases in cell death pathways, senescence and autophagy, focusing in particular on the most studied phosphatase PPM1D (PP2Cδ) as an example of the regulatory role of PP2Cs in cell death. The review should help to draw attention to the importance of PP2C family phosphatases in cell death checkpoints and to discover new targets for drug development.


  • Open Access

    Emerging Roles of Vitamin B12 in Aging and Inflammation

    by Sergey Yu. Simonenko, Daria A. Bogdanova, Nikita A. Kuldyushev

    Vitamin B12 (cobalamin) is an essential nutrient for humans and animals. Metabolically active forms of B12-methylcobalamin and 5-deoxyadenosylcobalamin are cofactors for the enzymes methionine synthase and mitochondrial methylmalonyl-CoA mutase. Malfunction of these enzymes due to a scarcity of vitamin B12 leads to disturbance of one-carbon metabolism and impaired mitochondrial function. A significant fraction of the population (up to 20%) is deficient in vitamin B12, with a higher rate of deficiency among elderly people. B12 deficiency is associated with numerous hallmarks of aging at the cellular and organismal levels. Cellular senescence is characterized by high levels of DNA damage by metabolic abnormalities, increased mitochondrial dysfunction, and disturbance of epigenetic regulation. B12 deficiency could be responsible for or play a crucial part in these disorders. In this review, we focus on a comprehensive analysis of molecular mechanisms through which vitamin B12 influences aging. We review new data about how deficiency in vitamin B12 may accelerate cellular aging. Despite indications that vitamin B12 has an important role in health and healthy aging, knowledge of the influence of vitamin B12 on aging is still limited and requires further research.


  • Open Access

    The Differential Effect of Senolytics on SASP Cytokine Secretion and Regulation of EMT by CAFs

    by Daria A. Bogdanova, Ekaterina D. Kolosova, Tamara V. Pukhalskaia, Ksenia A. Levchuk, Oleg N. Demidov, Ekaterina V. Belotserkovskaya

    The tumor microenvironment (TME) plays an essential role in tumor progression and in modulating tumor response to anticancer therapy. Cellular senescence leads to a switch in the cell secretome, characterized by the senescence-associated secretory phenotype (SASP), which may regulate tumorigenesis. Senolytic therapy is considered a novel anticancer strategy that eliminates the deleterious effects of senescent cells in the TME. Here, we show that two different types of senolytic drugs, despite efficiently depleting senescent cells, have opposite effects on cancer-associated fibroblasts (CAFs) and their ability to regulate epithelial–mesenchymal transition (EMT). We found that senolytic drugs, navitoclax and the combination of dasatinib/quercetin, reduced the number of spontaneously senescent and TNF-induced senescent CAFs. Despite the depletion of senescent cells, the combination of dasatinib/quercetin versus navitoclax increased the secretion of the SASP pro-inflammatory cytokine IL-6. This differential effect correlated with the promotion of enhanced migration and EMT in MC38 colorectal cancer cells. Our results demonstrate that some senolytics may have side effects unrelated to their senolytic activity and may promote tumorigenesis. We argue for more careful and extensive studies of the effects of senolytics on various aspects of tumor progression and tumor resistance to therapy before the senolytic strategy is implemented in the clinic.


  • Open Access

    Reliable Hallmarks and Biomarkers of Senescent Lymphocytes

    by Yuliya S. Martyshkina, Valeriy P. Tereshchenko, Daria A. Bogdanova, Stanislav A. Rybtsov

    The phenomenon of accumulation of senescent adaptive immunity cells in the elderly is attracting attention due to the increasing risk of global epidemics and aging of the global population. Elderly people are predisposed to various infectious and age-related diseases and are at higher risk of vaccination failure. The accumulation of senescent cells increases age-related background inflammation, “Inflammaging”, causing lymphocyte exhaustion and cardiovascular, neurodegenerative, autoimmune and cancer diseases. Here, we present a comprehensive contemporary review of the mechanisms and phenotype of senescence in the adaptive immune system. Although modern research has not yet identified specific markers of aging lymphocytes, several sets of markers facilitate the separation of the aging population based on normal memory and exhausted cells for further genetic and functional analysis. The reasons for the higher predisposition of CD8+ T-lymphocytes to senescence compared to the CD4+ population are also discussed. We point out approaches for senescent-lymphocyte-targeting markers using small molecules (senolytics), antibodies and immunization against senescent cells. The suppression of immune senescence is the most relevant area of research aimed at developing anti-aging and anti-cancer therapy for prolonging the lifespan of the global population.